Our goal is to ensure you feel confident and comfortable with your GLP-1 medication regimen, whether you're new to these treatments or looking to refine your injection technique
Multiple organ failure including sepsis-induced cardiac dysfunction seem to be the result of numerous factors as overwhelming inflammation and nitric oxide synthesis impairment associated with mitochondrial dysfunction and increased oxidative stress (Cecchini and Cecchini, 2020)
Clinical trials show that approximately 50% of weight loss is regained within one year of stopping GLP-1 therapy, and many patients return to baseline weight within 23 years
Frmacos como la semaglutida, la liraglutida y la tirzepatida han marcado un cambio en el manejo clnico del sobrepeso y la diabetes tipo 2, al ofrecer nuevas alternativas teraputicas
Recommended for people with a family history of MTC or multiple endocrine neoplasia type 2 (MEN2)
If you have used semaglutide or any other GLP-1 medication, you know these effects well